We are committed to addressing unmet needs in serious mental illness through the development of therapeutic options to support adults living with schizophrenia and bipolar I disorder.
The Alkermes Pathways Research Awards are open for applications! This program is open to all early-career investigators studying bipolar disorder or schizophrenia.
April marks National Minority Health Month, a time for us to reflect on the work still needed to address and break down existing barriers that keep minority communities from seeking mental health care.
Our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found that a vast majority of respondents who live with bipolar I disorder experienced medication side effects that negatively impacted their daily lives.
Results from our recent survey conducted with Harris Poll and Depression and Bipolar Support Alliance found an overwhelming majority of patients surveyed with bipolar 1 disorder felt it is a difficult and isolating experience.
May is Mental Health Month! The COVID-19 pandemic has put mental health front and center. This month we encourage everyone to learn more, share resources, and consider how you can support those who are living with mental illness.
This National Minority Health Month, we’re learning more about the disproportionate prevalence of mental illness, socioeconomic disparities & barriers to care in minority communities.
Dr. Rakesh Jain and Dr. Andrew Cutler guest hosted the Alkermes-sponsored MDEdge Psychiatry podcast to discuss the management of comorbidities & behavioral risk factors that may be present in people living with schizophrenia.
Responsible Business & Employee Engagement
| Alkermes
Meet Jessica Tamborski -- an Alkermes employee inspired by her daughter’s struggle with bipolar disorder who is proud to work at an organization that helps people living with serious mental illness.
This National Minority Health Month, we’re learning more about the disproportionate prevalence of mental illness, socioeconomic disparities & barriers to care in minority communities.
Today we observe World Bipolar Day to help lift the ~2.8% of American adults living with #bipolar disorder & coping with extreme highs & lows in mood & energy.
Dr. Rakesh Jain and Dr. Andrew Cutler guest hosted the Alkermes-sponsored MDEdge Psychiatry podcast to discuss the management of comorbidities & behavioral risk factors that may be present in people living with schizophrenia.
Early identification of a serious mental illness and intervention can be critical to disease management and improved long-term outcomes for individuals.
It's Brain Awareness Week! Raising awareness & advocating for research funding is crucial to improving the lives of people with schizophrenia & bipolar disorder.
We continue to recognize our passionate employees by spotlighting their “Why” for joining the Alkermes psychiatry team. Damon Harrell, VP of Marketing, shares why he’s inspired to make a difference for those living with serious mental illness.
Meet Jessica Tamborski -- an Alkermes employee inspired by her daughter’s struggle with bipolar disorder who is proud to work at an organization that helps people living with serious mental illness.
Psychiatrist Dr. Frank Chen sat down with PsychCentral.com’s Gabe Howard to discuss the benefits of telepsych and why it doesn’t need to be so intimidating.
Schizophrenia is a serious brain disorder affecting about 2.4 million adults in the United States. But exactly how does this disease affect certain parts of the brain?
Alkermes is committed to diversity, inclusion and belonging in various aspects of our business. We are purposeful about creating an environment that...